| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
From the Department of Pharmacology and Cardiovascular Research (G.G.D., B.M.-M., D.A.S., A.F., M.H.-M., W.P.D., Y.-X.W.), Berlex Biosciences, Richmond, Calif; The Scripps Research Institute (T.T., D.J.L.), La Jolla, Calif; and The Centre for Transgene Technology and Gene Therapy (P.C.), Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium.
Correspondence to Yi-Xin (Jim) Wang, Berlex Biosciences, Department of Pharmacology, PO Box 4099, 2600 Hilltop Dr, Richmond, CA 94804-0099. E-mail jim_wang{at}berlex.com
We have previously demonstrated that urokinase-type plasminogen activator (uPA) is highly expressed in the aneurysmal segment of the abdominal aorta (AAA) in apolipoprotein Edeficient (apoE-/-) mice treated with angiotensin II (Ang II). In the present study, we tested the hypothesis that uPA is essential for AAA formation in this model. An osmotic minipump containing Ang II (1.44 mg/kg per day) was implanted subcutaneously into 7- to 11-month-old male mice for 1 month. Ang II induced AAA in 9 (90%) of 10 hyperlipidemic mice deficient in apoE (apoE-/-/uPA+/+ mice) but in only 2 (22%) of 9 mice deficient in both apoE and uPA (apoE-/-/uPA-/- mice) (P<0.05). Although the expansion of the suprarenal aorta was significantly less in apoE-/-/uPA-/- mice than in apoE-/-/uPA+/+ mice, the aortic diameters of the aorta immediately above or below the suprarenal aorta were similar between the 2 groups. Ang II induced AAA in 7 (39%) of 18 strain-matched wild-type C57 black/6J control mice. The incidence was significantly higher in atherosclerotic apoE-deficient (apoE-/-) mice, in which 8 (100%) of 8 mice developed AAA. Only 1 (4%) of 27 uPA-/- mice developed AAA after Ang II treatment. We conclude the following: (1) uPA plays an essential role in Ang IIinduced AAA in mice with or without preexisting hyperlipidemia and atherosclerosis; (2) uPA deficiency does not affect the diameter of the nonaneurysmal portion of the aorta; and (3) atherosclerosis and/or hyperlipidemia promotes but is not essential for Ang IIinduced AAA formation in this model.
Key Words: urokinase-type plasminogen activator deficiency aneurysm atherosclerosis vascular inflammation
This article has been cited by other articles:
![]() |
S. Heeneman, J. C. Sluimer, and M. J.A.P. Daemen Angiotensin-Converting Enzyme and Vascular Remodeling Circ. Res., August 31, 2007; 101(5): 441 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gavazzi, C. Deffert, C. Trocme, M. Schappi, F. R. Herrmann, and K.-H. Krause NOX1 Deficiency Protects From Aortic Dissection in Response to Angiotensin II Hypertension, July 1, 2007; 50(1): 189 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. McCormick, D. Gavrila, and N. L. Weintraub Role of Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 461 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gitlin, D. B. Trivedi, R. Langenbach, and C. D. Loftin Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice Cardiovasc Res, January 1, 2007; 73(1): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. King, D. B. Trivedi, J. M. Gitlin, and C. D. Loftin Selective Cyclooxygenase-2 Inhibition With Celecoxib Decreases Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1137 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gavrila, W. G. Li, M. L. McCormick, M. Thomas, A. Daugherty, L. A. Cassis, F. J. Miller Jr, L. W. Oberley, K. C. Dellsperger, and N. L. Weintraub Vitamin E Inhibits Abdominal Aortic Aneurysm Formation in Angiotensin II-Infused Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1671 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Moran, M. McCann, M. Karan, P. Norman, N. Ketheesan, and J. Golledge Association of Osteoprotegerin With Human Abdominal Aortic Aneurysm Progression Circulation, June 14, 2005; 111(23): 3119 - 3125. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-X. Wang, B. Martin-McNulty, V. da Cunha, J. Vincelette, X. Lu, Q. Feng, M. Halks-Miller, M. Mahmoudi, M. Schroeder, B. Subramanyam, et al. Fasudil, a Rho-Kinase Inhibitor, Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice by Inhibiting Apoptosis and Proteolysis Circulation, May 3, 2005; 111(17): 2219 - 2226. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Henriques, J. Huang, S. S. D'Souza, A. Daugherty, and L. A. Cassis Orchidectomy, But Not Ovariectomy, Regulates Angiotensin II-Induced Vascular Diseases in Apolipoprotein E-Deficient Mice Endocrinology, August 1, 2004; 145(8): 3866 - 3872. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Daugherty and L. A. Cassis Mouse Models of Abdominal Aortic Aneurysms Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 429 - 434. [Abstract] [Full Text] |
||||
![]() |
K. Saraff, F. Babamusta, L. A. Cassis, and A. Daugherty Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1621 - 1626. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |